This item is provided by the institution :

Repository :
Annals of Gastroenterology
see the original item page
in the repository's web site and access all digital files if the item*
share




2007 (EN)
Chemotherapy of colorectal cancer (EN)

M. Vassilomanolakis, G. Koumakis,

SUMMARY Approximately 75% of all patients with colorectal carcinoma will present at a stage when all gross carcinoma can be surgically resected. Despite the high resectability rate, half of all patients with colorectal adenocarcinoma die from metastatic disease, primarily because of residual disease that is not apparent at the time of surgery. These patients are candidates for adjuvant local or systemic therapies. Systmemic chemotherapy is the treatment of choice as well as for patients with recurrent or metastatic disease. (EN)

info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion

Ελληνική Γαστροεντερολογική Εταιρία (EL)
Hellenic Society of Gastroenterology (EN)

2007-03-19


Hellenic Society of Gastroenterology (EN)

1792-7463
1108-7471
Annals of Gastroenterology; Volume 16, No 3 (2003) (EN)



*Institutions are responsible for keeping their URLs functional (digital file, item page in repository site)